Indian Council for Medical Research, ICMR has fast tracked the roll out of Global Solidarity Trial launched by the World Health Organization, WHO to help in finding an effective treatment for Covid-19.
By enrolling patients in multiple countries, the trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Importantly, the initiative provides for both speed and scale.
Speaking about India's participation, Prof Balram Bhargava, Secretary Department of Health Research and Director General, ICMR, said, "ICMR is working relentlessly to implement scientific interventions to combat the Covid-19 pandemic. The decision to join the WHO solidarity trial is an important step in this
The solidarity trial focuses to discover whether any of the drugs slow the disease's progression or improve survival, by enrolling patients in multiple countries. This special feature of the initiative is it provides both speed and scale.